TWI921406B - 特用於運鐵蛋白受體之雙環胜肽配體、包含該配體的多聚體結合複合物、藥物組合物、組織輸送複合物及其用途 - Google Patents

特用於運鐵蛋白受體之雙環胜肽配體、包含該配體的多聚體結合複合物、藥物組合物、組織輸送複合物及其用途

Info

Publication number
TWI921406B
TWI921406B TW110142158A TW110142158A TWI921406B TW I921406 B TWI921406 B TW I921406B TW 110142158 A TW110142158 A TW 110142158A TW 110142158 A TW110142158 A TW 110142158A TW I921406 B TWI921406 B TW I921406B
Authority
TW
Taiwan
Prior art keywords
seq
referred
paper
iii
isyc
Prior art date
Application number
TW110142158A
Other languages
English (en)
Chinese (zh)
Other versions
TW202233664A (zh
Inventor
艾倫 高恩斯
吉馬 伊莉莎白 摩德
麥可 里格比
普尼特 賽斯
麥可 斯凱尼爾
史蒂芬 史坦威
劉德維卡斯 烏爾博納斯
里喬頓 凱特林 范
Original Assignee
英商拜西可泰克斯有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2017927.1A external-priority patent/GB202017927D0/en
Priority claimed from GBGB2106903.4A external-priority patent/GB202106903D0/en
Application filed by 英商拜西可泰克斯有限公司 filed Critical 英商拜西可泰克斯有限公司
Publication of TW202233664A publication Critical patent/TW202233664A/zh
Application granted granted Critical
Publication of TWI921406B publication Critical patent/TWI921406B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
TW110142158A 2020-11-13 2021-11-12 特用於運鐵蛋白受體之雙環胜肽配體、包含該配體的多聚體結合複合物、藥物組合物、組織輸送複合物及其用途 TWI921406B (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB2017927.1A GB202017927D0 (en) 2020-11-13 2020-11-13 Bicyclic peptide ligands specific for transferrin
GB2017927.1 2020-11-13
GBGB2106903.4A GB202106903D0 (en) 2021-05-14 2021-05-14 Bicycle peptide ligands specific for transferrin
GB2106903.4 2021-05-14
US202163261820P 2021-09-29 2021-09-29
US63/261,820 2021-09-29

Publications (2)

Publication Number Publication Date
TW202233664A TW202233664A (zh) 2022-09-01
TWI921406B true TWI921406B (zh) 2026-04-11

Family

ID=81600834

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110142158A TWI921406B (zh) 2020-11-13 2021-11-12 特用於運鐵蛋白受體之雙環胜肽配體、包含該配體的多聚體結合複合物、藥物組合物、組織輸送複合物及其用途

Country Status (13)

Country Link
US (3) US11970555B2 (cg-RX-API-DMAC7.html)
EP (1) EP4244235A1 (cg-RX-API-DMAC7.html)
JP (1) JP7848202B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230107589A (cg-RX-API-DMAC7.html)
CN (1) CN116802190A (cg-RX-API-DMAC7.html)
AR (1) AR126029A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021376917A1 (cg-RX-API-DMAC7.html)
CA (1) CA3201414A1 (cg-RX-API-DMAC7.html)
IL (1) IL302713A (cg-RX-API-DMAC7.html)
MX (1) MX2023005624A (cg-RX-API-DMAC7.html)
SA (1) SA523440745B1 (cg-RX-API-DMAC7.html)
TW (1) TWI921406B (cg-RX-API-DMAC7.html)
WO (1) WO2022101633A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116802190A (zh) 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1(TfR1)的双环肽配体
GB202206431D0 (en) * 2022-05-03 2022-06-15 Bicycletx Ltd Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)
KR20260021596A (ko) * 2023-04-05 2026-02-13 아이오니스 파마수티컬즈, 인코포레이티드 Pln 발현을 감소시키는 화합물 및 방법
EP4788689A1 (en) 2023-10-03 2026-08-12 BicycleTx Limited Bicyclic peptide ligand complexes specific for tfr1
GB202316970D0 (en) * 2023-11-06 2023-12-20 Bicycletx Ltd Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104650186A (zh) * 2015-03-09 2015-05-27 中国药科大学 一种能够与TfR1特异性结合的活性肽及其应用
WO2016077840A2 (en) * 2014-11-14 2016-05-19 Ossianix, Inc. TfR SELECTIVE BINDING COMPOUNDS AND RELATED METHODS
TW201704261A (zh) * 2015-06-24 2017-02-01 Jcr製藥股份有限公司 通過血腦障壁之抗人類運鐵蛋白受體抗體

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
GB0914110D0 (en) 2009-08-12 2009-09-16 Medical Res Council Peptide libraries
GB201706477D0 (en) 2017-04-24 2017-06-07 Bicycle Therapeutics Ltd Modification of polypeptides
EP3615550A1 (en) 2017-04-27 2020-03-04 BicycleTx Limited Bicyclic peptide ligands and uses thereof
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
CA3080351A1 (en) 2017-11-02 2019-05-09 Ossianix, Inc. Improved tfr-selective binding peptides capable of crossing the blood brain barrier
CA3091775A1 (en) * 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
WO2020084305A1 (en) 2018-10-23 2020-04-30 Bicycletx Limited Bicyclic peptide ligands and uses thereof
EP3897849A1 (en) * 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201912320D0 (en) * 2019-08-28 2019-10-09 Bicycletx Ltd PBP Binding Bicyclic Peptide Ligands
CN116802190A (zh) 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1(TfR1)的双环肽配体

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016077840A2 (en) * 2014-11-14 2016-05-19 Ossianix, Inc. TfR SELECTIVE BINDING COMPOUNDS AND RELATED METHODS
CN104650186A (zh) * 2015-03-09 2015-05-27 中国药科大学 一种能够与TfR1特异性结合的活性肽及其应用
TW201704261A (zh) * 2015-06-24 2017-02-01 Jcr製藥股份有限公司 通過血腦障壁之抗人類運鐵蛋白受體抗體

Also Published As

Publication number Publication date
KR20230107589A (ko) 2023-07-17
JP2023549229A (ja) 2023-11-22
IL302713A (en) 2023-07-01
AU2021376917A1 (en) 2023-06-29
AU2021376917A9 (en) 2024-09-12
CA3201414A1 (en) 2022-05-19
US20240391959A1 (en) 2024-11-28
MX2023005624A (es) 2023-05-24
WO2022101633A1 (en) 2022-05-19
AR126029A1 (es) 2023-09-06
US20220194988A1 (en) 2022-06-23
EP4244235A1 (en) 2023-09-20
SA523440745B1 (ar) 2024-07-24
JP7848202B2 (ja) 2026-04-20
TW202233664A (zh) 2022-09-01
US20250340595A1 (en) 2025-11-06
US11970555B2 (en) 2024-04-30
CN116802190A (zh) 2023-09-22

Similar Documents

Publication Publication Date Title
US11970555B2 (en) Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)
CN1823088B (zh) 结合红细胞生成素受体的新肽
AU2004238870B8 (en) Novel peptides that bind to the erythropoietin receptor
US20130012685A1 (en) Novel peptides that bind to the erythropoietin receptor
JP2013173763A (ja) エリスロポエチンレセプターペプチドの処方および使用
TW201716431A (zh) 升糖素及glp-1共激動劑化合物
US20050203009A1 (en) VPAC1 selective antagonists and their pharmacological methods of use
JP2007534613A (ja) レラキシンスーパーファミリーペプチド類似体
US20250276073A1 (en) BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)
EA049362B1 (ru) БИЦИКЛИЧЕСКИЕ ПЕПТИДНЫЕ ЛИГАНДЫ, СПЕЦИФИЧЕСКИЕ ДЛЯ РЕЦЕПТОРА ТРАНСФЕРРИНА 1 (TfR1)
WO2025099047A1 (en) BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)
Kutina et al. Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats
JP2008519858A (ja) エリスロポエチンレセプターに結合する新規ペプチド
TW202615456A (zh) 用於肥胖症及第二型糖尿病(t2dm)的雙重及三重促效劑化合物
TW202608914A (zh) 用於肥胖症及t2dm之人類glp1r及gipr之單促效劑及雙重促效劑化合物
JP2000290295A (ja) N−アセチルグルコサミニルカルシトニン
CN117337295A (zh) 特异于trem2的双环肽配体
EA048412B1 (ru) Конъюгированные миметики гепсидина
JP2001199998A (ja) カルシトニン3,26位誘導体
HK1088906B (en) Peptides that bind to the erythropoietin receptor